Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Carnegie Fund - Medical Sub-Fund

+ Add to Watchlist

CARMEDI:LX

110.10 EUR 0.25 0.23%

As of 00:59:30 ET on 03/02/2015.

Snapshot for Carnegie Fund - Medical Sub-Fund (CARMEDI)

Year To Date: +15.71% 3-Month: +17.95% 3-Year: +32.85% 52-Week Range: 68.19 - 110.35
1-Month: +5.27% 1-Year: +45.64% 5-Year: +22.09% Beta vs LUXXX: 0.65

Mutual Fund Chart for CARMEDI

No chart data available.
  • CARMEDI:LX 110.10
  • 1M
  • 1Y
Interactive CARMEDI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for CARMEDI

Carnegie Fund - Medical Sub-Fund is an FCP incorporated in Luxembourg. The Fund's objective is long-term capital growth. The Fund invests globally in equities of companies operating in the pharmaceutical, biotechnology and medical technology sectors.

Inception Date: 12-18-1998 Telephone: 352-40-40-30-1
Managers: ANGELICA FATOUROS
Web Site: www.carnegieam.com

Fundamentals for CARMEDI

NAV (on 2015-03-02) 110.10
Assets (M) (on 2015-01-30) 679.45
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment -

Dividends for CARMEDI

No dividends reported

Fees & Expenses for CARMEDI

Front Load -
Back Load -
Current Mgmt Fee 1.70
Redemption Fee -
12b1 Fee -
Expense Ratio -

Top Fund Holdings for CARMEDI

Filing Date: 01/30/2015
Name Position Value % of Total
Gilead Sciences Inc 529,672 49,275,845 7.252%
Johnson & Johnson 413,186 37,116,213 5.463%
Novartis AG 410,862 35,680,667 5.251%
Carnegie Fund V - The Carnegie 108,460 34,702,903 5.107%
UnitedHealth Group Inc 351,158 33,783,468 4.972%
Amgen Inc 228,638 31,154,379 4.585%
Roche Holding AG 128,741 30,909,910 4.549%
Celgene Corp 283,838 30,745,376 4.525%
Pfizer Inc 1,036,315 29,021,769 4.271%
Merck & Co Inc 468,197 25,494,728 3.752%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil